News

A possible new therapy for pancreatic cancer

A study carried out with the participation of the team led by Dr. Bruno Sainz, Jr., a researcher at the "Alberto Sols" Biomedical Research Institute (IIBM-UAM) and supported by the Spanish Association Against Cancer (AECC), has identified a new Achilles' heel of pancreatic cancer stem cells: a part of the cell known as lysosomes, which represents a possible target for treating this type of cancer, one of the most aggressive of all malignancies.   Pancreatic cancer is a cancer that responds poorly to available treatments, due in part to the presence of cancer stem cells. This type of cell has the capacity to give rise to all of the other cancer cells present within the tumor and they are responsible for the origin of the tumor, its spread to other organs or metastasis, and relapse.    In order to find new...

The UAM, the IIBM (CSIC-UAM) and the FPCM receive the validation to carry out diagnostic PCR tests for Covid19

El Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), centro mixto del Consejo Superior de Investigaciones Científicas (CSIC) y la Universidad Autónoma de Madrid (UAM), ha recibido la validación del Instituto de Salud Carlos III, dependiente del Ministerio de Ciencia e Innovación, para realizar las pruebas PCR de detección molecular del coronavirus SARS-CoV-2, causante de la pandemia de Covid-19. https://www.csic.es/es/actualidad-del-csic/la-uam-el-iibm-csic-uam-y-la-fpcm-reciben-la-validacion-para-realizar-pruebas

The IIBM receives a donation from ALANTRA for the diagnosis of COVID19

The company ALANTRA has made a donation of 305,000 euros to the Higher Council for Scientific Research (CSIC) for the acquisition of two robots and reagents for molecular diagnosis of COVID19 at the Alberto Sols Institute for Biomedical Research (IIBM). The IIBM, a joint center of the CSIC and the Autonomous University of Madrid, participates in an effort in collaboration with the Department of Public Health, Preventive Medicine and Microbiology of the UAM School of Medicine to launch a diagnostic platform for COVID19 by PCR. The start was initiated at the request of the Carlos Tercero Health Institute via UAM Vice-Rectorate for Research, which coordinates the operation. ALANTRA's donation represents a decisive boost to the effort being made to launch the diagnostic platform, since the two robots will allow the processing of a significant number of samples in a short...

Isabel Varela-Nieto highlights in El País journal the importance of noise as a cause of premature deafness

El País (Health section) published on September 8 an article about the consequences of excessive noise exposure, especially among young people. Professor Varela-Nieto, group leader of the U761 of CIBERER, pointed out that, according to World Health Organization, approximately 50% of young people between 12 and 35 are at risk of hearing loss due to their listening habits with headphones. Excessive noise damages the sensory cells of the ear, which lack regeneration capacity and therefore they are irreversibly lost. Dr. Luis Lassaletta, head of Otolaryngology Service at La Paz Hospital and an associated researcher in the U761 unit, confirmed the increase in the number of patients with hearing loss secondary to noise exposure, and urged young people to protect their ear and go to the specialist when first symptoms appear.   The full article can be consulted at:...

Isabel Varela-Nieto, awarded for her scientific career

Isabel Varela-Nieto, group leader of U761 CIBERER unit at Alberto Sols Biomedical Research Institute (CSIC-UAM), has been awarded with Morgagni medal for her professional career in the study of inner ear and hearing loss. Giovanni Battista Morgagni (1682 - 1771), doctor of Medicine and Philosophy, and professor at the University of Padua for more than 50 years, is considered the father of modern pathological anatomy.   Professor Varela-Nieto has been dedicated for last 30 years to the study of the molecular basis of auditory function and the pathophysiology of hearing loss, combining development studies in chicken embryos and in vivo assays with genetically modified mice. In recent years she has focused her research on rare hearing loss, both in animal models and in patients, in collaboration with clinicians at La Paz Hospital. She received the award from...

Pilar Santisteban appointed member of the Technical Scientific Committee of the State Research Agency

On April 30, Pilar Santisteban has been appointed member of the Technical Scientific Committee of the AEI. The proposal made by the Governing Committee of the Agency, is part of the consolidation phase of the Agency, where the scientific advice of the Committee will be essential.   The agency has a Director elected in Public Contest, and has established its new structure by developing autonomous administrative capacities. The director, with the advice of the Scientific and Technical Committee, is beginning to develop calls under the new organization. Participation in the Scientific Committee of our colleague is a pride for the institute and we take advantage of this platform to congratulate Pilar for her appointment.  

Engineered immune cells produce antibodies to fight HIV

Engineered immune cells produce antibodies to fight HIV   B cells that are removed from patients' bloodstreams and genetically altered may one day allow more effective vaccines for HIV, influenza and hepatitis   Alicia González Martín, principal investigator of the Institute for Biomedical Research Alberto Sols (IIBm-CSIC/UAM), has co-developed with James Voss, Raiees Andrabi and Dennis Burton from The Scripps Research Institute of California a new technique to engineer human primary B cells to produce antibodies that can neutralize, or disable, human immunodeficiency virus (HIV). This new technique could one day be used to generate new, broadly acting vaccines or therapies against not only HIV but other pathogens such as influenza and hepatitis. The study entitled: "Reprogramming the antigen specificity of B cells using...

The Fero Foundation has awarded Dr. Bruno Sainz, Head of the Cancer Stem Cells and Tumor Microenvironment Group of Biomedical Research Institute “Alberto Sols”

The Fero Foundation has awarded Dr. Bruno Sainz, Head of the Cancer Stem Cells and Tumor Microenvironment Group of Biomedical Research Institute "Alberto Sols" of the Autonomous University of Madrid (UAM), with the distinguished Fero Research Grant for his translational research project in oncology. The Foundation has awarded Dr. Sainz both for his strong career path and for the strength of his proposal, a promising approach that has the ultimate goal of fighting pancreatic cancer by identifying new therapeutic targets associated with cancer stem cells, which represent between 1 and 5% of the total tumor mass. In addition, this year and for the first time there have been two projects awarded in the fifteenth celebration of the Fero Research Grant awards, which took place on December 3, 2018 at the Westin Palace in Madrid. The other winner was Dr....

L'Oréal-UNESCO For Women in Science Awards 2018

Alicia González Martín, a principal investigator in the Biomedical Research Institute Alberto Sols (IIBm-CSIC/UAM), was one of the 5 young scientist that received the L'Oréal-UNESCO For Women in Science Award in its 13th edition. The award took into consideration her scientific trajectory as well as the proposed project "New regulators of immune tolerance and autoimmune diseases".   The L'Oréal-UNESCO For Women in Science program has been working for 20 years to increase the visibility of women in sciences and to inspire scientific careers in girls and young women. It has recognized the accomplishments of outstanding female scientists worldwide and promoted the visibility of their work, making them a reference for future generations.   November 28th, 2018 - Madrid